The Immunogenicity and Safety of the Vaccination of Human Papillomavirus Vaccine and Measles-Mumps-Rubella Vaccine

Clinical trial NCT05279248 · UNKNOWN

Trial details

NCT number: NCT05279248
Sponsor: Zhejiang Provincial Center for Disease Control and Prevention
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Human Papilloma Virus Infection Type 16 Human Papilloma Virus Infection Type 18 Measles Rubella Mumps

Start date: 2021-08-25
Primary completion: 2022-12-31
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.